Please login to the form below

Not currently logged in
Email:
Password:

MSD

This page shows the latest MSD news and features for those working in and with pharma, biotech and healthcare.

Opdivo trial overshadows BMS financial results

Opdivo trial overshadows BMS financial results

dominated by Merck &Co/MSD’s rival Keytruda (pembrolizumab).

Latest news

More from news
Approximately 45 fully matching, plus 318 partially matching documents found.

Latest Intelligence

  • The first, my last, my everything The first, my last, my everything

    It’s a subtle but important nuance. It’s a similar story elsewhere, with companies like Roche, Janssen and MSD ‘partnering with patients’ to understand their needs and identify opportunities for

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    Last month, Johnson &Johnson Innovation, Takeda and Evotec became the latest pharma research groups to join the initiative, alongside existing strategic partners AbbVie, Astex Pharmaceuticals, Eisai, Lilly and MSD.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    9. Vitrakvi – a novel addition to the immune-oncology market. Earlier this year Merck &Co/MSD became the first company to secure approval for a ‘tissue agnostic’ drug when its ... Merck/MSD looks to have gained a dominant position in checkpoint

  • Combined immunotherapies – potential and pitfalls Combined immunotherapies – potential and pitfalls

    The recent failed phase 3 trial of a combination of MSD’s monoclonal antibody Keytruda (pembrolizumab) and InCyte Corporation’s epacadostat in metastatic melanoma is a case in point he says.

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    Moreover, it’s multi-funded by BMS, Amgen, MSD and J&J to identify inefficiencies and collaboratively develop benchmarks or tools to improve resource allocations towards what matters most to patients,

More from intelligence
Approximately 4 fully matching, plus 27 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 46 partially matching documents found.

Latest from PMHub

  • Attigo (part of the Mednet Group)

    Johnson and Johnson. University of Leeds. Lundbeck Mind. MSD. Novo. Nordisk.

  • Wearables and Healthcare

    So impressive was the success of SCI-diabetes, the Scottish Government in collaboration with various stakeholders including MSD Healthcare Services, decided to unlock the data potential of the entire nation’s

  • IGNIFI

    Allergan . Biogen . Boehringer Ingelheim . Danone Nutricia . Ferring Pharmaceuticals . MSD Healthcare Services .

  • Active Life Ahead: MSD, Simponi - Brand Campaign

    44 7595 003744. Address:. Greencoat House. Francis Street. London. SW1P 1DH. United Kingdom.

  • VCCP Health

    2017, Active Life Ahead, Simponi (MSD). PMEA – Finalist, Excellence in Patient Education.

More from PMHub
Approximately 0 fully matching, plus 21 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics